Renivace and cardiac disorder Patient Reports February 13, 2012
Renivace Side Effects Report #5201103-4
Renivace side effect was reported by a Physician from JAPAN on Dec 20, 2006. Male patient, 66 years of age, was diagnosed with hypertension, gastrointestinal haemorrhage, hyperlipidaemia, coronary arterial stent insertion and was treated with Renivace. After drug was administered, patient experienced the following side effects: acute myocardial infarction, blood pressure immeasurable, cardiac disorder, cardio-respiratory arrest, cardiogenic shock, coronary artery occlusion, coronary artery thrombosis, excoriation, gastrointestinal haemorrhage. Renivace dosage: 2.5 MG Q DAY PO. During the same period patient was treated with GASTER D, LIPITOR, ASPIRIN, PLAVIX, SIGMART, LUPRAC, ARTIST. Patient was hospitalized. Patient died on 10/31/2006.
Renivace Side Effects Report #5162013-4
Renivace side effect was reported by a Physician from JAPAN on Nov 06, 2006. Male patient, 66 years of age, was diagnosed with hypertension, gastrointestinal haemorrhage, hyperlipidaemia, coronary arterial stent insertion and was treated with Renivace. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blister, cardiac disorder, cardio-respiratory arrest, cardiogenic shock, erythema, excoriation, gastrointestinal haemorrhage. Renivace dosage: 2.5 MG Q DAY PO. During the same period patient was treated with GASTER D, LIPITOR, ASPIRIN, PLAVIX, SIGMART, LUPRAC, ARTIST. Patient was hospitalized. Patient died on 10/31/2006.Renivace Side Effects Report #5167489-4
Renivace side effect was reported by a Physician from JAPAN on Nov 14, 2006. Male patient, 66 years of age, was diagnosed with hypertension, gastrointestinal haemorrhage, hyperlipidaemia, coronary arterial stent insertion and was treated with Renivace. After drug was administered, patient experienced the following side effects: acute myocardial infarction, apparent life threatening event, blood pressure immeasurable, cardiac disorder, cardio-respiratory arrest, condition aggravated, gastrointestinal haemorrhage, pyrexia, skin haemorrhage. Renivace dosage: 2.5 MG Q DAY; PO. During the same period patient was treated with GASTER D, LIPITOR, ASPIRIN, PLAVIX, SIGMART, LUPRAC, ARTIST. Patient was hospitalized. Patient died on 10/31/2006.
Renivace Side Effects Report #5346772-3
Renivace side effect was reported by a Physician from JAPAN on May 18, 2007. Male patient, 61 years of age, was diagnosed with hypertension, arrhythmia
, angina pectoris and was treated with Renivace. After drug was administered, patient experienced the following side effects: cardiac disorder, liver function test abnormal. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with BAYASPIRIN, SELOKEN, SIGMART, FRANDOL, BAYLOTENSIN. Patient was hospitalized. Patient recovered.Renivace Side Effects Report #5376563-9
Renivace side effect was reported by a Physician from JAPAN on June 13, 2007. Male patient, 61 years of age, was diagnosed with hypertension, arrhythmia
and was treated with Renivace. After drug was administered, patient experienced the following side effects: cardiac disorder, liver function test abnormal. Renivace dosage: 2.5 MG QD ORAL. During the same period patient was treated with BAYASPIRIN, SELOKEN, SIGMART. Patient was hospitalized. Patient recovered.Renivace Side Effects Report #5385982-6
Renivace side effect was reported by a Physician from JAPAN on June 21, 2007. Male patient, 61 years of age, was diagnosed with hypertension, arrhythmia
, angina pectoris and was treated with Renivace. After drug was administered, patient experienced the following side effects: cardiac disorder, liver function test abnormal. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with ACETYLSALICYLIC ACID SRT, SELOKEN, SIGMART, FRANDOL, BAYLOTENSIN. Patient was hospitalized. Patient recovered.
Renivace and cardiac disorder 